… insight has allowed his lab to develop a potential new treatment in which by completely but temporarily suspending … or IGF1 corrected many defects of MECP2 mutation. Both treatment forms have advanced to clinical trials . Late last … toward FDA approval as the first-ever mechanism-based treatment for a neurodevelopmental disorder , Sur said . …